SG11202008531RA - Oxazino-quinazoline and Oxazino-quinoline Type Compound, Preparation Method and Uses Thereof - Google Patents

Oxazino-quinazoline and Oxazino-quinoline Type Compound, Preparation Method and Uses Thereof

Info

Publication number
SG11202008531RA
SG11202008531RA SG11202008531RA SG11202008531RA SG11202008531RA SG 11202008531R A SG11202008531R A SG 11202008531RA SG 11202008531R A SG11202008531R A SG 11202008531RA SG 11202008531R A SG11202008531R A SG 11202008531RA SG 11202008531R A SG11202008531R A SG 11202008531RA
Authority
SG
Singapore
Prior art keywords
oxazino
quinazoline
preparation
type compound
quinoline type
Prior art date
Application number
SG11202008531RA
Other languages
English (en)
Inventor
Qiang Zhang
Shannan Yu
Zhongxiang Wang
Shouye Feng
Nanqiao Zheng
Hailong Yang
Leifu Yang
Hongbo Zhang
Likai Zhou
Zhanqiang Xu
Original Assignee
Beijing Scitech Mq Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Scitech Mq Pharmaceuticals Ltd filed Critical Beijing Scitech Mq Pharmaceuticals Ltd
Publication of SG11202008531RA publication Critical patent/SG11202008531RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SG11202008531RA 2018-03-06 2019-03-05 Oxazino-quinazoline and Oxazino-quinoline Type Compound, Preparation Method and Uses Thereof SG11202008531RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810182708 2018-03-06
PCT/CN2019/077028 WO2019170088A1 (zh) 2018-03-06 2019-03-05 一种噁嗪并喹唑啉与噁嗪并喹啉类化合物及其制备方法和应用

Publications (1)

Publication Number Publication Date
SG11202008531RA true SG11202008531RA (en) 2020-10-29

Family

ID=67846907

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202008531RA SG11202008531RA (en) 2018-03-06 2019-03-05 Oxazino-quinazoline and Oxazino-quinoline Type Compound, Preparation Method and Uses Thereof

Country Status (12)

Country Link
US (1) US11548900B2 (zh)
EP (1) EP3760633B1 (zh)
JP (1) JP7190755B2 (zh)
KR (1) KR102526281B1 (zh)
CN (1) CN110229171B (zh)
AU (1) AU2019230859B2 (zh)
CA (1) CA3093323C (zh)
DK (1) DK3760633T3 (zh)
ES (1) ES2905985T3 (zh)
PL (1) PL3760633T3 (zh)
SG (1) SG11202008531RA (zh)
WO (1) WO2019170088A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023081637A1 (en) 2021-11-02 2023-05-11 Enliven Therapeutics, Inc. Fused tetracyclic quinazoline derivatives as inhibitors of erbb2
WO2024059558A1 (en) * 2022-09-13 2024-03-21 Enliven Inc. Polycyclic quinazolines for inhibition of erbb2

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214690B2 (en) * 2001-02-23 2007-05-08 Ligand Pharmaceuticals Incorporated Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
CN102382106A (zh) * 2010-08-30 2012-03-21 黄振华 苯胺取代的喹唑啉衍生物
CN103965213A (zh) * 2013-02-02 2014-08-06 江苏奥赛康药业股份有限公司 7,8-二氢-6H-[1,4]噁嗪[3,2-g]喹唑啉类衍生物及其制备方法和用途
CN104530063B (zh) * 2015-01-13 2017-01-18 北京赛特明强医药科技有限公司 喹唑啉并杂环类化合物及其制备方法和作为用于治疗癌症的表皮生长因子受体抑制剂的应用
CN110229172B (zh) * 2018-03-06 2020-12-25 北京赛特明强医药科技有限公司 一种酰基取代的噁嗪并喹唑啉类化合物、制备方法及其应用

Also Published As

Publication number Publication date
ES2905985T3 (es) 2022-04-12
CN110229171A (zh) 2019-09-13
JP2021515768A (ja) 2021-06-24
US20210040114A1 (en) 2021-02-11
EP3760633A4 (en) 2021-01-06
CA3093323C (en) 2022-11-29
AU2019230859B2 (en) 2021-10-21
KR102526281B1 (ko) 2023-04-27
CA3093323A1 (en) 2019-09-12
PL3760633T3 (pl) 2022-04-19
JP7190755B2 (ja) 2022-12-16
WO2019170088A1 (zh) 2019-09-12
EP3760633B1 (en) 2021-12-15
EP3760633A1 (en) 2021-01-06
AU2019230859A1 (en) 2020-10-22
KR20200127223A (ko) 2020-11-10
DK3760633T3 (da) 2022-01-31
CN110229171B (zh) 2021-03-12
US11548900B2 (en) 2023-01-10

Similar Documents

Publication Publication Date Title
SG11202007740TA (en) Pyrimidine-fused cyclic compound, preparation method therefor and application thereof
IL288104A (en) Heterocyclic compounds, preparation methods and their use
SG11202105850YA (en) Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof
SG11202106706TA (en) Heterocyclic compound intermediate, preparation method therefor and application thereof
IL272089A (en) Compounds, preparations and methods
EP3584239A4 (en) O-AMINOHETEROARYL-ALKYNYL-CONTAINING COMPOUND, MANUFACTURING METHOD AND USES THEREOF
EP3676297A4 (en) COMPOUNDS, COMPOSITIONS AND PROCESSES
ZA201906131B (en) Herbicidal mixture, composition and method
SG11202007554TA (en) Dioxazoline compound, preparation method therefor, and uses thereof
EP3569602A4 (en) IMIDAZOPYRAZINE COMPOUND, METHOD OF MANUFACTURING THEREFORE AND USE OF IT
EP3640248A4 (en) AMINOPYRIMIDINE COMPOUND, PROCESS FOR PREPARATION AND USE
SG11202007521PA (en) Urea-substituted aromatic ring-linked dioxazoline compound, preparation method therefor, and uses thereof
EP3715342A4 (en) COMPONENT CONTAINING FLUOROSULFONYL, INTERMEDIATE THEREOF, RELATED PREPARATION PROCESS AND CORRESPONDING USE
GB201904104D0 (en) Composition, method and use
EP3112351A4 (en) Naphthylamide compound, preparation method and use thereof
GB2576614B (en) Compositions, uses and methods
EP3447054A4 (en) CONNECTION AND MANUFACTURING METHOD THEREFOR, COMPOSITION AND APPLICATION THEREOF
GB201804163D0 (en) Uses, compositions and methods
EP3543248A4 (en) PHOSPHORESCENT COMPLEX OF PtAg2, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF
IL282817A (en) New material, production method, and its use
EP3789384A4 (en) FORMAMIDE COMPOUND, PROCESS FOR PREPARATION AND USE
EP3581561A4 (en) BIARYL COMPOUND, MANUFACTURING METHOD AND USE THEREOF
SG11202008531RA (en) Oxazino-quinazoline and Oxazino-quinoline Type Compound, Preparation Method and Uses Thereof
PL3750893T3 (pl) Związek dioksazoliny, sposób jego wytwarzania oraz jego zastosowania
EP3392263A4 (en) POLYPEPTIDE COMPOUND, METHOD FOR PREPARING THE SAME, AND USE THEREOF